Acelity Holdings IPO Research Information

Acelity Holdings IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Acelity Holdings, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Acelity Holdings	TBD - NYSE	Withdrawn	$0.00	$0.00	TBD
Underwriter(s): J.P. Morgan, Goldman Sachs & Co., BofA Merrill Lynch
Co-Manager(s): Morgan Stanley, Barclays, Credit Suisse, RBC Capital Markets, UBS Investment Bank
Industry: Health Care
Filing(s): Filed 2015-08-26

About Acelity Holdings (adapted from Acelity Holdings prospectus):
Acelity is a leading global medical technology company committed to the development and commercialization of advanced wound care and regenerative medicine solutions.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "TBD" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.